Frazier Life Sciences Management, L.P.
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1892134
PALO ALTO, CA
Position in ARQT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$258,909,678
+$26,266,199 QoQ
Shares Held
9,874,511
0.0% QoQ
Ownership
7.86%
of shares outstanding
% of Portfolio
5.64%
of 13F equity value
Holder Rank
#3
of 269 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Frazier Life Sciences Management, L.P. holds $4,497,017,185 across 37 Biotechnology names. ARQT ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
7,679,684 | $899,060,605 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
18,589,235 | $623,725,004 | |
| 3 | ERAS |
Erasca, Inc.
|
24,975,188 | $457,545,444 | |
| 4 | MBX |
MBX Biosciences, Inc.
|
6,652,013 | $367,191,117 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
9,874,511 | $258,909,678 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
9,939,447 | $185,370,686 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
481,307 | $178,887,372 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
5,032,915 | $150,182,183 |
All Filings in ARQT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $258,909,678 | 9,874,511 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $232,643,479 | 9,874,511 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $286,755,799 | 9,874,511 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $186,134,532 | 9,874,511 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $138,440,644 | 9,874,511 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $137,401,841 | 8,785,284 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $122,379,006 | 8,785,284 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $81,703,141 | 8,785,284 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $81,703,141 | 8,785,284 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $87,062,164 | 8,785,284 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $28,308,469 | 8,764,232 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $46,113,271 | 8,684,232 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $82,760,730 | 8,684,232 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $95,526,552 | 8,684,232 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $128,526,633 | 8,684,232 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $165,955,673 | 8,684,232 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $179,733,483 | 8,434,232 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $162,443,308 | 8,434,232 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||